Information
-
Trademark
-
88812806
-
Serial Number
88812806
-
Registration Number
6318323
-
International Classifications
-
Filing Date
February 27, 2020
4 years ago
-
Registration Date
April 13, 2021
3 years ago
-
Transaction Date
April 13, 2021
3 years ago
-
Status Date
April 13, 2021
3 years ago
-
Published for Opposition Date
January 26, 2021
3 years ago
-
Location Date
April 13, 2021
3 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
SAUNDERS, ANDREA DAWN
-
Attorney Docket Number
4444-245TM
Attorney Name
Jeffrey H. Greger, Esq.
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
4000
Mark Identification
ELIGO BIOSCIENCE
Case File Statements
- D10000: "BIOSCIENCE"
- GS0031: Non-medicated toiletry preparations and cosmetic preparations; cosmetics; non-medicated skin creams; cosmetic preparations for skin regeneration; non-medicated skin serums; non-medicated skin treatment preparation for cosmetic purposes; cosmetic preparations for slimming purposes; non-medicated balms for use on skin; hair care cosmetics; cosmetic preparations for the face and body; non-medicated cosmetics and toiletry preparations active in the microbiome space
- GS0051: Dietetic food and beverages, adapted for medical and veterinary use; diet pills; food supplements for humans and animals; medical preparations for slimming purposes; medicated supplements for foodstuffs for animals, food supplements for humans and animals produced by organic farming or made from goods produced by organic farming; Pharmaceutical products, namely, probiotic and prebiotic for maintenance of microbiome health; medical preparations for the treatment of infection, cancer, inflammatory disease, auto-immune disease and veterinary preparations for treatment of infection, cancer, inflammatory disease, auto-immune disease; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use; diagnostic agents for medical use; drug delivery agents in the form of antimicrobials to eradicate bacteria carrying a targeted DNA sequence; antibodies for medical or veterinary purposes, namely, monoclonal and polyclonal antibodies for use in disease testing and treatment; cultures of microorganisms and biological tissues for medical or veterinary use; microbicides for industrial and institutional manufacturing processes; bacterial and bacteriological preparations for medical or veterinary use; chemical, biochemical or biological preparations for medical or veterinary use, namely, for the treatment of infection, cancer, inflammatory disease, auto-immune disease; preparations of cultures of microorganisms for medical and veterinary use; pharmaceutical preparations and substances for cancer treatment; diagnostic reagents for veterinary and medical use and chemical reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; preparations for detecting genetic predispositions for medical use; treatment or diagnostic preparations for medical and veterinary use active in the microbiome space
- GS0101: Surgical apparatus and instruments for medical, dental and veterinary use; diagnostics and analysis apparatus for medical use for testing DNA, RNA, microbiome and bacteria; medical instruments for analyzing and identification of bacteria; DNA and RNA testing apparatus for medical purposes; medical apparatus used in the treatment and the diagnostic of bacterial disorders; applicators for anti-bacterial preparations, namely, introducers, spatulas, syringes and needles for medical use; implantable devices for the subcutaneous release of medicated substances; samplers for medical use, namely, bacteria and blood sampling tubes, bacteria sampling pads, bacteria sampling pipettes; genetic testing apparatus for medical purposes; surgical apparatus and instruments for dental, medical and veterinary use in connection with the diagnosis and treatment of the microbiome
- GS0421: Medical and pharmacological research services; consultation relating to pharmaceutical research and development; consultation relating to bacteriology research; development of pharmaceutical preparations and medicines; conducting clinical trials for others; research and development in the field of pharmaceuticals and biotechnology; bacteriological research and testing; biological, clinical and medical research services in the field of the diagnosis, editing, and functionalization of human or animal microbiomes; biological, clinical and medical research services in the field of the diagnosis and treatment of infection, cancer, inflammatory disease, auto-immune disease microbiome; medical research laboratory services; scientific research in the field of genetics; preparation of scientific reports with respect to biotechnology; research and development in the field of microbial manipulation and biotherapy; research and development in the field of the microbiome
- GS0441: Medical services; veterinary services; hygienic and beauty care for human beings or animals; advice concerning animal feeding; veterinary surgical services; services concerning the care of pets namely non-medicated pet grooming; Medical analysis for treatment purposes provided by medical laboratories relating to the treatment of animals; medical information concerning veterinary pharmaceutical products; genetic analysis for medical or veterinary purposes; medical testing for the diagnosis and treatment of persons; consulting and information with respect to medicine; conducting of medical examinations for insurance purposes; medical analysis services for the diagnosis and treatment purposes provided by medical laboratories; medical services in the field of microbial manipulation and biotherapy; medical services with respect to the removal, treatment and processing of human cells and biological compounds active in the microbiome space
- TR0010: The wording "ELIGO" has no meaning in a foreign language.
Case File Event Statements
-
4/13/2021 - 3 years ago
20 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/26/2021 - 3 years ago
19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/26/2021 - 3 years ago
18 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
1/6/2021 - 3 years ago
17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
12/17/2020 - 3 years ago
16 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
12/17/2020 - 3 years ago
15 - DATA MODIFICATION COMPLETED
Type: DMCC
-
12/17/2020 - 3 years ago
14 - ASSIGNED TO LIE
Type: ALIE
-
12/3/2020 - 3 years ago
13 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
12/3/2020 - 3 years ago
12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
12/3/2020 - 3 years ago
11 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
12/3/2020 - 3 years ago
10 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
11/18/2020 - 4 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/18/2020 - 4 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/18/2020 - 4 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/18/2020 - 4 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/18/2020 - 4 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
5/18/2020 - 4 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
5/18/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/5/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
3/5/2020 - 4 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP